Skip to main content
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Videos
SABCS 2023 HR+/HER2-
Real-world Outcomes Following Initiation of Abemaciclib in Patients With Brain Metastases Secondary to HR+/HER2- Metastatic Breast Cancer
Read More
SABCS 2023 HR+/HER2-
Primary Analysis of HER2CLIMB-02: Addition of Tucatinib to Trastuzumab Emtansine in Previously Treated Patients with HER2-Positive Metastatic Breast Cancer
Read More
SABCS 2023 HR+/HER2-
INAVO120 Phase III Study: Treatment of Patients With PIK3CA-mutant, HR+/HER2- Locally Advanced or Metastatic Breast Cancer With Invavolisib in Combination With Palbociclib and Fulvestrant
Read More
SABCS 2023 HR+/HER2-
Abemaciclib and NSAI for 1L Treatment of HR+/HER2- Advanced Breast Cancer: Long-term Survival Data Reported
Read More
ESMO Early Breast Cancer
Recent Clinical Trials of Neoadjuvant Immunotherapy in Breast Cancer
Read More
ESMO Early Breast Cancer
New Developments on Prognostic Markers for Patients With Early Breast Cancer
Read More
ESMO Early Breast Cancer
Evolving Adjuvant Treatment Landscape for HR+/HER2- Early Breast Cancer
Read More
ADC Therapy Treatment HER2+ and HER2-Low mBC
Educating on HER2-Low mBC
Read More
ADC Therapy Treatment HER2+ and HER2-Low mBC
Fostering Shared Treatment Decision-Making
Read More
ADC Therapy Treatment HER2+ and HER2-Low mBC
Setting Appropriate Patient Goals of Therapy
Read More
1
2
3
Page 1 of 3
Results 1 - 10 of 26